Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mapping the invisible threat: a feasibility study on antibiotic resistance in the DRC

NCT ID NCT06821282

Recruiting now Knowledge-focused Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tests whether it is possible to set up a system to monitor antibiotic resistance at a general referral hospital in semirural Kinshasa, Democratic Republic of Congo. Researchers will enroll about 210 patients with suspected bloodstream infections to collect blood samples, identify bacterial strains, and test which antibiotics they resist. The goal is to fill knowledge gaps about antimicrobial resistance in sub-Saharan Africa and build local research capacity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could establish a model for tracking antibiotic resistance in resource-limited settings, guiding local treatment decisions.
What could go wrong
This is a small feasibility study at a single hospital, so findings may not apply broadly. The focus is on measuring processes, not testing a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTEREMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial infectious disease with sepsis malaria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BACTEREMIA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kinshasa, Democratic Republic of Congo, Kinshasa School of Public Health

    RECRUITING

    Kinshasa, Kinshasa City, BP 11850, Democratic Republic of the Congo

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.